Everest Medicines Limited

Getting company information...

Press Releases by Everest Medicines Limited
Filter by year Year
All
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

Everest Medicines today announced that the first patient has been enrolled in a global multi-center Phase I clinical trial...

Everest Medicines today announced that the results of its Asian multicenter Phase III ENLIGHT UC study (ES101002) of etrasimod...

On August 29, Everest Medicines (1952.HK) announced its interim results for the six months ended June 30, 2025. The Company's...

Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on...

Everest Medicines (HKEX: 1952.HK) today announced that the supplemental New Drug Application (sNDA) for NEFECON has received...